Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NRX Pharmaceuticals (NRXP) EBT Margin (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed EBT Margin for 2 consecutive years, with 538.25% as the latest value for Q4 2025.

  • Quarterly EBT Margin changed N/A to 538.25% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1378.29% through Dec 2025, down 950350.0% year-over-year, with the annual reading at 1378.2% for FY2025, N/A changed from the prior year.
  • EBT Margin for Q4 2025 was 538.25% at NRX Pharmaceuticals, up from 1661.98% in the prior quarter.
  • The five-year high for EBT Margin was 2696.09% in Q1 2024, with the low at 1661.98% in Q3 2025.